Hyperinflammatory syndrome, natural killer cell function, and genetic polymorphisms in the pathogenesis of severe dengue by Vuong, NL, Cheung, K-W, Periaswamy, B, Vi, TT, Duyen, HTL, Leong, YS, Binte Hamis, ZN, Gregorova, M, Ooi, EE, Sessions, O, Rivino, L, Yacoub, S

Kinetics of cardiovascular and inflammatory biomarkers in paediatric dengue shock syndrome by Chanh, HQ, Trieu, HT, Tran Kim, H, Huynh Ngoc Thien, V, Huyen, VNT, Moncada, A, Thanh Nguyen Thi, K, Duyen, HTL, Nguyen-Lyle, N, Vuong, NL, Lam, PK, McBride, A, Phan, TQ, Dong Thi Hoai, T, Wills, B, Yacoub, S

Metformin as adjunctive therapy for dengue in overweight and obese patients: a protocol for an open-label clinical trial (MeDO) by Nguyen, NM, Chanh, HQ, Tam, DTH, Vuong, NL, Chau, NTX, Chau, NVV, Phong, NT, Trieu, HT, Luong Thi Hue, T, Cao Thi, T, Dinh The, T, Duyen, HTL, Van, NTT, Nguyen Than Ha, Q, Rivino, L, Gallagher, P, Jones, NK, Geskus, RB, Kestelyn, E, Yacoub, S

Combination of inflammatory and vascular markers in the febrile phase of dengue is associated with more severe outcomes by Vuong, NL, Lam, PK, Ming, DKY, Duyen, HTL, Nguyen, NM, Tam, DTH, Duong Thi Hue, K, Chau, NV, Chanpheaktra, N, Lum, LCS, Pleités, E, Simmons, CP, Rosenberger, KD, Jaenisch, T, Bell, D, Acestor, N, Halleux, C, Olliaro, PL, Wills, BA, Geskus, R, Yacoub, S